Erratum
- PMID: 26386410
- PMCID: PMC4633935
- DOI: 10.1093/neuonc/nov201
Erratum
Erratum for
-
Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma.Neuro Oncol. 2015 Jun;17(6):862-7. doi: 10.1093/neuonc/nou350. Epub 2015 Jan 7. Neuro Oncol. 2015. PMID: 25572329 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
